Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Medical Clinics of North America|February 13, 2017
Myelodysplastic Syndromes: Updates and NuancesKim-Hien T Dao
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2013
Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapiesKim-Hien T Dao, Jeffrey W Tyner
Hematology. American Society of Hematology. Education Program|December 6, 2015
What's different about atypical CML and chronic neutrophilic leukemia?Kim-Hien T Dao, Jeffrey W Tyner
Current Hematologic Malignancy Reports|October 7, 2017
Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid LeukemiaKim-Hien T Dao, Jeffrey W Tyner, Jason Gotlib
BMC Cancer|January 14, 2010
Rac1 and Cdc42 are regulators of HRasV12-transformation and angiogenic factors in human fibroblastsDaniel M Appledorn, Kim-Hien T Dao, Sandra O'Reilly, et al.
Cold Spring Harbor Molecular Case Studies|December 19, 2018
Two myeloid leukemia cases with rare <i>FLT3</i> fusionsHaijiao Zhang, Aleksandra Paliga, Evie Hobbs, et al.
Leukemia Research Reports|September 3, 2014
Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemiaKim-Hien T Dao, Magdolna B Solti, Julia E Maxson, et al.
Cureus|February 13, 2016
Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid LeukemiaVishesh Khanna, Scott T Pierce, Kim-Hien T Dao, et al.
Molecular Biology of the Cell|June 21, 2013
The PI3K/Akt1 pathway enhances steady-state levels of FANCLKim-Hien T Dao, Michael D Rotelli, Brieanna R Brown, et al.
Blood|June 2, 2012
FANCL ubiquitinates β-catenin and enhances its nuclear functionKim-Hien T Dao, Michael D Rotelli, Curtis L Petersen, et al.
Pageof 2